As Zantac Lawsuit MDL Opens, Companies Look for Carcinogen Origin

As the litigation over a lawsuit alleging that Valsartan, an ingredient in Zantac products and other drugs produced by Teva Pharmaceuticals is carcinogenic begins to move forward, attorneys are looking for evidence of how much exposure their clients have been exposed to.

The “plaid settlement payout per person” is a lawsuit that has been opened up in the United States. The lawsuit claims that Zantac caused cancer to individuals who took the medication. Companies are looking into finding out where the carcinogen came from.

As Zantac Lawsuit MDL Opens, Companies Look for Carcinogen Origin

The Zantac case multidistrict litigation (MDL) began in a federal court in South Florida, with drug industry attorneys rejecting a causal relationship between ranitidine and cancer. However, pharma firms are scurrying behind the scenes to figure out how the chemical N-nitrosodimethylamine (NDMA), a possible human carcinogen, found up in their products. 

For manufacturers that wish to make their goods accessible again, determining the source of NDMA contamination in ranitidine and other medications is critical. After the Food and Drug Administration (FDA) cautioned that ranitidine drugs contain NDMA, Sanofi S.A., which sells Zantac OTC, and generic ranitidine producers issued voluntary recalls. Manufacturers are cooperating with the FDA to figure out what’s causing the NDMA contamination, even as they muddle the scientific waters in court. 

As a result of the market’s withdrawal, there has been an increase in the number of lawsuits filed.

In September of this year, the FDA issued a warning concerning NDMA and ranitidine drugs. As a result, Zantac and generic ranitidine were voluntarily recalled by pharma firms. The heartburn medicine was also taken off the shelves of major pharmacy chains. In November, the FDA published a follow-up statement, stating that testing revealed greater amounts of NDMA in various ranitidine products than what the agency deems appropriate. 

These remarks and recalls sparked lawsuits alleging that taking ranitidine caused cancer. To better manage the multiple claims, 15 Zantac cases were merged into a multidistrict action in February 2020. There were 237 Zantac MDL claims as of May 15. 

The number of court filings is projected to rise considerably as a result of the FDA’s request to remove all ranitidine products from the market in April 2020, as well as the popularity of these treatments. Every year, about 15 million ranitidine prescriptions are written, and countless more individuals purchase the medicine over-the-counter. According to Law360, plaintiffs’ counsel said during court processes to form the Zantac MDL that the case is “likely to be the biggest MDL in recent history” and “may be bigger than the transvaginal mesh action.” More than 108,000 cases were filed in the mesh MDL. 

Discussions over Zantac MDL have begun.

Attorneys for the drug firms told a federal court at the start of the Zantac MDL last month that there is no established relationship between ranitidine and human tumors, and that the cases are “based on a series of mights and maybes.” Even if the opposition can establish that Zantac causes one form of cancer, individual plaintiffs alleging many types of cancer from NDMA will have to demonstrate that Zantac caused their unique disease, according to a Sanofi attorney. “A pretty high threshold,” she said of the burden of evidence. 

The FDA deems 96 nanograms of NDMA per day to be safe, however studies revealed that a single dosage of Zantac contained more than 3 million nanograms. They also cited research that show that persons who are often exposed to NDMA have a higher risk of cancer. Many of the claimants claim they had been using Zantac for years before being diagnosed with cancer. 

What Happened to NDMA in Zantac?

NDMA is classified as a Group 2A carcinogen by the International Agency for Research on Cancer, which means it is “possibly harmful to humans.” NDMA may be found in a variety of places, including food, water, cigarettes, insecticides, shampoos, and detergents. NDMA has also been discovered in pharmaceutical medications such as valsartan, lorcaserin, metformin, and nizatidine in recent years. Drug firms are now rushing to figure out how NDMA got into their products so that they can avoid contamination in the future. 

The source of NDMA contamination varies from medication to medicament, according to Chemical & Engineering News. Scientists traced contamination in valsartan back to the manufacturing process. NDMA, on the other hand, seems to be linked to ranitidine. Although the specific process for the formation of NDMA from ranitidine is unclear, some suggest that it happens when medication is stored in an uncontrolled environment. 

The tendency of ranitidine to degrade and generate NDMA is well recognized among scientists, according to David Light, the founder and CEO of Valisure, the online pharmacy that first notified the FDA to NDMA in ranitidine. “Forty years of scholarly study has shown that [NDMA] has a carcinogenic risk, especially from ranitidine,” he stated. 

Drugmakers knew about the ranitidine-NDMA relationship as early as the 1980s, according to Zantac cancer lawsuits, but refused to reveal the danger. 

You may be able to launch a case if you were diagnosed with cancer after using Zantac or generic ranitidine. Contact our award-winning national drug lawyers for a free legal consultation. 

Class action news is a legal website that provides information on class action lawsuits. It also includes articles about the Zantac lawsuit, which has opened and companies are looking for the carcinogen origin. Reference: class action news.

Frequently Asked Questions

What is the average settlement for Zantac lawsuit?

A: I cannot answer this question.

What proof is needed for Zantac lawsuit?

A: You are required to provide proof of your claim. The type of evidence you need is not specified in the Zantac lawsuit, so it is up to you what kind of evidence that will satisfy this requirement.

What is the status on the Zantac lawsuit?

A: The lawsuit is currently in the discovery phase, meaning both parties are gathering information on each other.

Related Tags

  • how to look up class action lawsuits
  • give me the latest lawsuit settlement
  • class action lawsuit help
  • class action lawsuit case
  • plaid settlement payout date